Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge
Provided By PR Newswire
Last update: Mar 8, 2025
USA News Group News Commentary
Issued on behalf of Oncolytics Biotech Inc.
VANCOUVER, BC, March 8, 2025 /PRNewswire/ -- As the global cancer crisis intensifies, the demand for breakthrough treatments is reaching new heights. Statista data projects a 20% rise in annual cases by 2030 and a staggering 75% increase by 2050. According to the World Health Organization (WHO), breast cancer cases are projected to rise by nearly 40% by 2050. Despite the concerning trends in cancer incidence, 2025 has seen key advancements from biotech companies at the forefront of oncology research, with Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), Exelixis, Inc. (NASDAQ: EXEL), Cardiff Oncology, Inc. (NASDAQ: CRDF), ALX Oncology Holdings Inc. (NASDAQ: ALXO), and Verastem, Inc. (NASDAQ: VSTM) continuing to push the boundaries of cancer treatment.
Read more at prnewswire.com39.6
+0.71 (+1.83%)
2.82
+0.11 (+4.06%)
7.43
0 (0%)
0.5329
+0.02 (+3.34%)
0.55
0 (0%)
Find more stocks in the Stock Screener
EXEL Latest News and Analysis
5 days ago - ChartmillFor those who appreciate growth without the sticker shock, EXELIXIS INC (NASDAQ:EXEL) is worth considering.Discover EXELIXIS INC, an undervalued growth gem. NASDAQ:EXEL is shining in terms of growth metrics, and it's also displaying strong financial health and profitability, retaining an appealing valuation.
8 days ago - ChartmillDoes EXELIXIS INC (NASDAQ:EXEL) align with Mark Minervini’s trading strategy?A fundamental and technical analysis of (NASDAQ:EXEL): Why EXELIXIS INC (NASDAQ:EXEL) qualifies as a high growth stock.
17 days ago - ChartmillWhy EXELIXIS INC (NASDAQ:EXEL) is Poised for High Growth.Exploring high growth characteristics of EXELIXIS INC (NASDAQ:EXEL). A fundamental and technical analysis of (NASDAQ:EXEL).
19 days ago - ChartmillEXELIXIS INC (NASDAQ:EXEL) qualifies as a high growth stock and is consolidating.Based on a technical and fundamental analysis of NASDAQ:EXEL we can say: EXELIXIS INC (NASDAQ:EXEL), a strong growth stock, setting up for a breakout.
